Effect of Nitinol on Metabolic and Coagulation Activity of Endothelial Cells Culture
We studied the effect of nitinol, the most prevalent material for endovascular stents, on metabolic and coagulation activity of a primary culture of human umbilical vein endothelial cells (HUVEC). Metabolic activity was evaluated using MTS-test and by the level of stable NO metabolites in the conditioned medium, coagulation activity was assessed by activity of von Willebrand factor (vWF) and levels of plasminogen activator inhibitor-1 (PAI-1) and soluble endothelial protein C receptors (sEPCR). Exposure to nitinol reduced metabolic activity of the cell culture by 11.1% in comparison with the control (p<0.001). Although absolute activity of vWF and absolute level of sEPCR were elevated, incubation with nitinol did not lead to a statistically significant elevation of these parameters in comparison with the control, which can indicate the absence of substantial hypercoagulation effects of nitinol..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:171 |
|---|---|
| Enthalten in: |
Bulletin of experimental biology and medicine - 171(2021), 4 vom: Aug., Seite 480-482 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kalinin, R. E. [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© Springer Science+Business Media, LLC, part of Springer Nature 2021 |
|---|
| doi: |
10.1007/s10517-021-05255-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2077053925 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2077053925 | ||
| 003 | DE-627 | ||
| 005 | 20230512235410.0 | ||
| 007 | tu | ||
| 008 | 221220s2021 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10517-021-05255-8 |2 doi | |
| 035 | |a (DE-627)OLC2077053925 | ||
| 035 | |a (DE-He213)s10517-021-05255-8-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a 12 |2 ssgn | ||
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 084 | |a 44.00 |2 bkl | ||
| 084 | |a 42.00 |2 bkl | ||
| 100 | 1 | |a Kalinin, R. E. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of Nitinol on Metabolic and Coagulation Activity of Endothelial Cells Culture |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer Science+Business Media, LLC, part of Springer Nature 2021 | ||
| 520 | |a We studied the effect of nitinol, the most prevalent material for endovascular stents, on metabolic and coagulation activity of a primary culture of human umbilical vein endothelial cells (HUVEC). Metabolic activity was evaluated using MTS-test and by the level of stable NO metabolites in the conditioned medium, coagulation activity was assessed by activity of von Willebrand factor (vWF) and levels of plasminogen activator inhibitor-1 (PAI-1) and soluble endothelial protein C receptors (sEPCR). Exposure to nitinol reduced metabolic activity of the cell culture by 11.1% in comparison with the control (p<0.001). Although absolute activity of vWF and absolute level of sEPCR were elevated, incubation with nitinol did not lead to a statistically significant elevation of these parameters in comparison with the control, which can indicate the absence of substantial hypercoagulation effects of nitinol. | ||
| 700 | 1 | |a Suchkov, I. A. |4 aut | |
| 700 | 1 | |a Mzhavanadze, N. D. |4 aut | |
| 700 | 1 | |a Korotkova, N. V. |4 aut | |
| 700 | 1 | |a Zhurina, O. N. |4 aut | |
| 700 | 1 | |a Povarov, V. O. |4 aut | |
| 700 | 1 | |a Surov, I. Yu. |4 aut | |
| 700 | 1 | |a Bozhenova, A. D. |4 aut | |
| 700 | 1 | |a Strelnikova, E. A. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bulletin of experimental biology and medicine |d Springer US, 1958 |g 171(2021), 4 vom: Aug., Seite 480-482 |w (DE-627)129934992 |w (DE-600)390407-6 |w (DE-576)015493512 |x 0007-4888 |7 nnns |
| 773 | 1 | 8 | |g volume:171 |g year:2021 |g number:4 |g month:08 |g pages:480-482 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s10517-021-05255-8 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 936 | b | k | |a 44.00 |q VZ |
| 936 | b | k | |a 42.00 |q VZ |
| 951 | |a AR | ||
| 952 | |d 171 |j 2021 |e 4 |c 08 |h 480-482 | ||